- Home
- CERS vs EOT Comparison
CERS vs EOT Comparison
Compare CERS & EOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- EOT
- Stock Information
- Founded
- CERS 1991
- EOT 2009
- Country
- CERS United States
- EOT United States
- Employees
- CERS N/A
- EOT N/A
- Industry
- CERS EDP Services
- EOT Investment Bankers/Brokers/Service
- Sector
- CERS Technology
- EOT Finance
- Exchange
- CERS Nasdaq
- EOT Nasdaq
- Market Cap
- CERS 324.3M
- EOT 272.2M
- IPO Year
- CERS 1997
- EOT N/A
- Fundamental
- Price
- CERS $1.58
- EOT $16.59
- Analyst Decision
- CERS Buy
- EOT
- Analyst Count
- CERS 3
- EOT 0
- Target Price
- CERS $3.17
- EOT N/A
- AVG Volume (30 Days)
- CERS 1.2M
- EOT 38.7K
- Earning Date
- CERS 10-30-2024
- EOT 01-01-0001
- Dividend Yield
- CERS N/A
- EOT 4.51%
- EPS Growth
- CERS N/A
- EOT N/A
- EPS
- CERS N/A
- EOT N/A
- Revenue
- CERS $176,229,000.00
- EOT N/A
- Revenue This Year
- CERS $26.47
- EOT N/A
- Revenue Next Year
- CERS $11.48
- EOT N/A
- P/E Ratio
- CERS N/A
- EOT N/A
- Revenue Growth
- CERS 14.71
- EOT N/A
- 52 Week Low
- CERS $1.38
- EOT $14.63
- 52 Week High
- CERS $2.59
- EOT $18.30
- Technical
- Relative Strength Index (RSI)
- CERS 38.88
- EOT 24.11
- Support Level
- CERS $1.53
- EOT $16.56
- Resistance Level
- CERS $1.83
- EOT $17.58
- Average True Range (ATR)
- CERS 0.11
- EOT 0.18
- MACD
- CERS -0.03
- EOT -0.09
- Stochastic Oscillator
- CERS 13.89
- EOT 2.69
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About EOT Eaton Vance Municipal Income Trust EATON VANCE NATIONAL MUNICIPAL OPPORTUNITIES TRUST
Eaton Vance National Municipal Opportunities Trust is a diversified, closed-end management investment company. The company's investment objective is to provide current income exempt from regular federal income tax and to achieve capital appreciation. It invests a majority of its assets in debt obligations issued by or on behalf of states, territories, and possessions of the United States, including the District of Columbia, and their political subdivisions, agencies, or instrumentalities, the interest on which is exempt from regular federal income tax.